EUVIMEDEUVIMED entdecken
Crossref

Lipoprotein(a) in Clinical Practice: From Risk Marker to Actionable Signal

Michael Shapiro

Federal Practitioner · 03.11.2026 · 43 (Suppl 5)

DOI: 10.12788/fp.0780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Federal Practitioner, online erschienen am 03.11.2026. Verfasst von Michael Shapiro.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Shapiro, M. (2026). Lipoprotein(a) in Clinical Practice: From Risk Marker to Actionable Signal. Federal Practitioner, 43(Suppl 5). https://doi.org/10.12788/fp.0780

Vancouver

Shapiro M. Lipoprotein(a) in Clinical Practice: From Risk Marker to Actionable Signal. Federal Practitioner. 2026;43(Suppl 5). doi:10.12788/fp.0780

BibTeX
@article{Shapiro2026,
  author = {Shapiro, Michael},
  title = {Lipoprotein(a) in Clinical Practice: From Risk Marker to Actionable Signal},
  journal = {Federal Practitioner},
  year = {2026},
  volume = {43},
  number = {Suppl 5},
  doi = {10.12788/fp.0780}
}
Kostenlos starten →